92 related articles for article (PubMed ID: 2851901)
1. [The beta-endorphin level in climacteric women].
Schurz B; Egarter C; Huber J; Wimmer-Greinecker G; Weindlmayer-Goettl M; Metka M
Zentralbl Gynakol; 1988; 110(22):1428-32. PubMed ID: 2851901
[TBL] [Abstract][Full Text] [Related]
2. Beta-endorphin levels during the climacteric period.
Schurz B; Wimmer-Greinecker G; Metka M; Heytmanek G; Egarter C; Knogler W
Maturitas; 1988 May; 10(1):45-50. PubMed ID: 2840557
[TBL] [Abstract][Full Text] [Related]
3. [Neurophysiologic processes in the production of climacteric hot flushes].
Schurz B; Metka M; Heytmanek G; Kurz C; Enzelsberger H
Gynakol Rundsch; 1989; 29(4):241-3. PubMed ID: 2560761
[No Abstract] [Full Text] [Related]
4. Menopausal hot flushes, plasma calcitonin and beta-endorphin. A preliminary report.
Tepper R; Pardo J; Ovadia J; Beyth Y
Gynecol Obstet Invest; 1992; 33(2):98-101. PubMed ID: 1559634
[TBL] [Abstract][Full Text] [Related]
5. Menopausal hot flushes and plasma beta-endorphins.
Tepper R; Neri A; Kaufman H; Schoenfeld A; Ovadia J
Obstet Gynecol; 1987 Aug; 70(2):150-2. PubMed ID: 2955261
[TBL] [Abstract][Full Text] [Related]
6. Steroid replacement treatment increases beta-endorphin and beta-lipotropin plasma levels in postmenopausal women.
Genazzani AR; Petraglia F; Facchinetti F; Grasso A; Alessandrini G; Volpe A
Gynecol Obstet Invest; 1988; 26(2):153-9. PubMed ID: 2851506
[TBL] [Abstract][Full Text] [Related]
7. Veralipride for hot flushes induced by a gonadotropin-releasing hormone agonist: a controlled study.
Vercellini P; Sacerdote P; Trespidi L; Manfredi B; Panerai AE; Crosignani PG
Fertil Steril; 1994 Nov; 62(5):938-42. PubMed ID: 7926138
[TBL] [Abstract][Full Text] [Related]
8. Effect of estrogen on the growth hormone response to the alpha-adrenergic agonist clonidine in women with menopausal flushing.
Tulandi T; Lal S; Guyda H
J Clin Endocrinol Metab; 1987 Jul; 65(1):6-10. PubMed ID: 2884230
[TBL] [Abstract][Full Text] [Related]
9. Veralipride versus conjugated oestrogens: a double-blind study in the management of menopausal hot flushes.
Wesel S; Bourguignon RP; Bosuma WB
Curr Med Res Opin; 1984; 8(10):696-700. PubMed ID: 6327190
[TBL] [Abstract][Full Text] [Related]
10. A comparison of oestrogen-progestogen with clonidine in the climacteric syndrome.
Sonnendecker EW; Polakow ES
S Afr Med J; 1980 Nov; 58(19):753-6. PubMed ID: 6252641
[TBL] [Abstract][Full Text] [Related]
11. [Effect of hormone substitution therapy on AT III in women in the climacteric].
Enzelsberger H; Heytmanek H; Kurz C; Metka M
Zentralbl Gynakol; 1991; 113(11):639-44. PubMed ID: 1656654
[TBL] [Abstract][Full Text] [Related]
12. Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study.
Chandeying V; Sangthawan M
J Med Assoc Thai; 2007 Sep; 90(9):1720-6. PubMed ID: 17957910
[TBL] [Abstract][Full Text] [Related]
13. [Climacteric disturbances. 2. Therapy of climacteric disturbances].
Döring GK
Fortschr Med; 1976 Jul; 94(19):1118-26. PubMed ID: 184019
[TBL] [Abstract][Full Text] [Related]
14. Serum beta-endorphin response to stress before and after operation under fentanyl anesthesia in neonates, infants and preschool children.
Mirilas P; Mentessidou A; Kontis E; Antypa E; Makedou A; Petropoulos AS
Eur J Pediatr Surg; 2010 Mar; 20(2):106-10. PubMed ID: 20084599
[TBL] [Abstract][Full Text] [Related]
15. [Clinical-physiological characteristics and hormone therapy of patients with typical form of climacteric syndrome].
Gudkova MA; Kulakov VI; Krymskaia ML; Solov'eva AD
Akush Ginekol (Mosk); 1994; (6):49-52. PubMed ID: 7892951
[TBL] [Abstract][Full Text] [Related]
16. Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding.
Marslew U; Overgaard K; Riis BJ; Christiansen C
Obstet Gynecol; 1992 Feb; 79(2):202-10. PubMed ID: 1309944
[TBL] [Abstract][Full Text] [Related]
17. Conjugated equine estrogens reverse the effects of aging on central and peripheral allopregnanolone and beta-endorphin levels in female rats.
Genazzani AR; Stomati M; Bernardi F; Luisi S; Casarosa E; Puccetti S; Genazzani AD; Palumbo M; Luisi M
Fertil Steril; 2004 Mar; 81 Suppl 1():757-66. PubMed ID: 15019806
[TBL] [Abstract][Full Text] [Related]
18. [Drug information: agents for treatment of gynecologic diseases. Hormone substitution in the climacteric].
Lumholtz IB
Sygeplejersken; 1979 Aug; 79(32):13. PubMed ID: 229578
[No Abstract] [Full Text] [Related]
19. [Drug information: agents for the treatment of gynecologic diseases. Hormone substitution in the climacteric].
Lumholtz IB
Sygeplejersken; 1979 Sep; 79(36):17. PubMed ID: 229579
[No Abstract] [Full Text] [Related]
20. [Psychometric aspects of estrogen therapy in climacteric woman (study of 122 women after menopause].
Wenderlein JM
Z Klin Psychol Psychother; 1981; 29(3):263-7. PubMed ID: 6274104
[No Abstract] [Full Text] [Related]
[Next] [New Search]
